{"qas": [{"question": "Who argued against regulators?", "id": "571af9889499d21900609bcb", "answers": [{"text": "Ben Goldacre", "answer_start": 0}], "is_impossible": false}, {"question": "Who argued that drug regulators were greater serving the interests of the drug companies than the patients?", "id": "571d3ae3dd7acb1400e4c25c", "answers": [{"text": "Ben Goldacre", "answer_start": 0}], "is_impossible": false}, {"question": "The business friendships between which parties have been criticized?", "id": "571d3ae3dd7acb1400e4c25d", "answers": [{"text": "regulator and company employees", "answer_start": 389}], "is_impossible": false}, {"question": "Goldacre argued that which party didn't require that new drugs be improved at all?", "id": "571d3ae3dd7acb1400e4c25e", "answers": [{"text": "regulators", "answer_start": 437}], "is_impossible": false}, {"plausible_answers": [{"text": "Ben Goldacre", "answer_start": 0}], "question": "Who argued against the public?", "id": "5ad3ad2f604f3c001a3febe5", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "Ben Goldacre", "answer_start": 0}], "question": "Who argued that drug regulators were greater serving the interests of patients than the drug companies?", "id": "5ad3ad2f604f3c001a3febe6", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "regulator and company employees", "answer_start": 389}], "question": "The business friendships between which parties have been praised?", "id": "5ad3ad2f604f3c001a3febe7", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "regulators", "answer_start": 29}], "question": "The FDA argued that which party didn't require that new drugs be improved at all?", "id": "5ad3ad2f604f3c001a3febe8", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "Ben Goldacre", "answer_start": 0}], "question": "Who argues that regulators do not require that new regulators offer an improvement?", "id": "5ad3ad2f604f3c001a3febe9", "answers": [], "is_impossible": true}], "context": "<a0_0><a1_0><b4_0><b5_0><b8_0>Ben Goldacre<b8_0/><b5_0/><b4_0/><a1_0/><a0_0/> has argued that <b7_0>regulators<b7_0/> \u2013 such as the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, or the Food and Drug Administration (FDA) in the United States \u2013 advance the interests of the drug companies rather than the interests of the public due to revolving door exchange of employees between the regulator and the companies and friendships develop between <a2_0><b6_0>regulator and company employees<b6_0/><a2_0/>. He argues that <a3_0>regulators<a3_0/> do not require that new drugs offer an improvement over what is already available, or even that they be particularly effective."}